Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
TJX Companies
TJX
$172B
| $3.34M | ﹤0.01% |
62,700
-1,875,800
| -97% | -$93.5M |
|
|
ICAD
2052
DELISTED
iCAD Inc
ICAD
| $3.33M | ﹤0.01% |
644,670
+1,677
| +0.3% | +$8.11K |
|
2053
Citi Trends
CTRN
$575M
| $3.33M | ﹤0.01% |
172,525
+32,400
| +23% | +$665K |
|
2054
Republic Services
RSG
$64.8B
| $3.33M | ﹤0.01% |
41,400
-824,061
| -95% | -$63.5M |
|
|
BLCM
2055
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $3.32M | ﹤0.01% |
98,596
+53,373
| +118% | +$1.78M |
|
|
BPTH
2056
DELISTED
Bio-Path Holdings Inc
BPTH
| $3.31M | ﹤0.01% |
8,129
+6,979
| +607% | +$1.28M |
|
|
HT
2057
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $3.31M | ﹤0.01% |
193,400
-285,700
| -60% | -$5.15M |
|
|
CALA
2058
DELISTED
Calithera Biosciences, Inc
CALA
| $3.3M | ﹤0.01% |
24,510
+11,545
| +89% | +$1.21M |
|
2059
HEICO Corp
HEI
$50.1B
| $3.29M | ﹤0.01% |
34,646
-242,326
| -87% | -$21.1M |
|
|
HALL
2060
DELISTED
Hallmark Financial Services, Inc.
HALL
| $3.28M | ﹤0.01% |
31,566
+2,216
| +8% | +$227K |
|
|
NSTG
2061
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.28M | ﹤0.01% |
+136,900
| New | +$3.15M |
|
2062
Hecla Mining
HL
$9.54B
| $3.27M | ﹤0.01% |
1,423,590
-89,600
| -6% | -$225K |
|
2063
Atkore
ATKR
$3.16B
| $3.27M | ﹤0.01% |
152,000
-243,458
| -62% | -$5.44M |
|
2064
Universal Logistics Holdings
ULH
$414M
| $3.27M | ﹤0.01% |
166,250
-162,900
| -49% | -$3.38M |
|
|
EXTN
2065
DELISTED
Exterran Corporation
EXTN
| $3.26M | ﹤0.01% |
193,600
-33,500
| -15% | -$596K |
|
|
MPX
2066
DELISTED
Marine Products Corp
MPX
| $3.25M | ﹤0.01% |
241,202
-15,100
| -6% | -$223K |
|
2067
Alerian MLP ETF
AMLP
$13B
| $3.25M | ﹤0.01% |
64,760
+56,540
| +688% | +$2.77M |
|
|
SRRA
2068
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.24M | ﹤0.01% |
47,383
+2,163
| +5% | +$139K |
|
|
VSA
2069
VisionSys AI
VSA
$8.74M
| $3.24M | ﹤0.01% |
239
+27
| +13% | +$429K |
|
|
HMHC
2070
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $3.23M | ﹤0.01% |
+444,100
| New | +$3.99M |
|
2071
Ultralife
ULBI
$91.3M
| $3.23M | ﹤0.01% |
314,055
+48,055
| +18% | +$431K |
|
2072
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.5B
| $3.22M | ﹤0.01% |
+50,000
| New | +$3.18M |
|
2073
Verastem
VSTM
$502M
| $3.22M | ﹤0.01% |
90,767
+28,292
| +45% | +$1.12M |
|
|
AGRX
2074
DELISTED
Agile Therapeutics
AGRX
| $3.22M | ﹤0.01% |
1,067
+97
| +10% | +$206K |
|
2075
Ingevity
NGVT
$2.53B
| $3.21M | ﹤0.01% |
+30,400
| New | +$3.05M |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.